• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents.莱姆病螺旋体伯氏疏螺旋体对四种抗菌药物的体外和体内敏感性
Antimicrob Agents Chemother. 1987 Feb;31(2):164-7. doi: 10.1128/AAC.31.2.164.
2
Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.莱姆病螺旋体伯氏疏螺旋体对头孢呋辛及其他抗菌药物的体外和体内敏感性比较
Antimicrob Agents Chemother. 1990 Nov;34(11):2133-6. doi: 10.1128/AAC.34.11.2133.
3
In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.
J Antimicrob Chemother. 1990 Jan;25 Suppl A:33-8. doi: 10.1093/jac/25.suppl_a.33.
4
In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics.来自不同来源的30株疏螺旋体菌株对8种抗微生物化疗药物的体外敏感性。
Infection. 1996 Jan-Feb;24(1):60-3. doi: 10.1007/BF01780660.
5
In vitro and in vivo susceptibility of Borrelia burgdorferi.伯氏疏螺旋体的体外和体内药敏性
Eur J Clin Microbiol. 1987 Aug;6(4):424-6. doi: 10.1007/BF02013102.
6
Sensitivity of Borrelia burgdorferi strains isolated in the Czech Republic.在捷克共和国分离出的伯氏疏螺旋体菌株的敏感性。
Cent Eur J Public Health. 2001 Feb;9(1):38-40.
7
In-vitro and in-vivo antibiotic susceptibilities of Lyme disease Borrelia isolated in China.中国分离的莱姆病疏螺旋体的体外和体内抗生素敏感性
J Infect Chemother. 2000 Mar;6(1):65-7. doi: 10.1007/s101560050053.
8
Susceptibility of the Lyme disease spirochete to seven antimicrobial agents.莱姆病螺旋体对七种抗菌药物的敏感性。
Yale J Biol Med. 1984 Jul-Aug;57(4):549-53.
9
Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi.
Eur J Clin Microbiol Infect Dis. 1989 Jul;8(7):651-3. doi: 10.1007/BF01968150.
10
In vitro susceptibility of European human Borrelia burgdorferi sensu stricto strains to antimicrobial agents.欧洲人伯氏疏螺旋体严格意义上的菌株对抗菌药物的体外敏感性。
Int J Antimicrob Agents. 2013 Mar;41(3):288-91. doi: 10.1016/j.ijantimicag.2012.11.016. Epub 2013 Jan 9.

引用本文的文献

1
Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.Romo1 衍生抗菌肽是一种新型抗微生物剂,可用于治疗脓毒症小鼠模型中的多重耐药菌。
mBio. 2020 Apr 14;11(2):e03258-19. doi: 10.1128/mBio.03258-19.
2
Lyme Disease Frontiers: Reconciling Biology and Clinical Conundrums.莱姆病前沿:协调生物学与临床难题
Pathogens. 2019 Dec 16;8(4):299. doi: 10.3390/pathogens8040299.
3
In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease.伯氏疏螺旋体分离株对三种常用于治疗马莱姆病的抗生素的体外敏感性。
BMC Vet Res. 2017 Sep 29;13(1):293. doi: 10.1186/s12917-017-1212-3.
4
Culture of the entire mouse to determine whether cultivable Borrelia burgdorferi persists in infected mice treated with a five-day course of Ceftriaxone.对整个小鼠进行培养,以确定在用头孢曲松进行为期五天的疗程治疗的感染小鼠中,是否仍存在可培养的伯氏疏螺旋体。
Antimicrob Agents Chemother. 2014 Nov;58(11):6701-3. doi: 10.1128/AAC.03751-14. Epub 2014 Aug 25.
5
Ineffectiveness of tigecycline against persistent Borrelia burgdorferi.替加环素对持续性伯氏疏螺旋体无效。
Antimicrob Agents Chemother. 2010 Feb;54(2):643-51. doi: 10.1128/AAC.00788-09. Epub 2009 Dec 7.
6
Antibiotic treatment of animals infected with Borrelia burgdorferi.对感染伯氏疏螺旋体的动物进行抗生素治疗。
Clin Microbiol Rev. 2009 Jul;22(3):387-95. doi: 10.1128/CMR.00004-09.
7
Evidence of a conjugal erythromycin resistance element in the Lyme disease spirochete Borrelia burgdorferi.莱姆病螺旋体伯氏疏螺旋体中配偶红霉素抗性元件的证据。
Int J Antimicrob Agents. 2007 Dec;30(6):496-504. doi: 10.1016/j.ijantimicag.2007.07.013. Epub 2007 Oct 1.
8
Erythromycin resistance in Borrelia burgdorferi.伯氏疏螺旋体对红霉素的耐药性。
Antimicrob Agents Chemother. 2002 Nov;46(11):3637-40. doi: 10.1128/AAC.46.11.3637-3640.2002.
9
Efficacy of short-course ceftriaxone therapy for Borrelia burgdorferi infection in C3H mice.短疗程头孢曲松治疗C3H小鼠伯氏疏螺旋体感染的疗效
Antimicrob Agents Chemother. 2002 Jan;46(1):132-4. doi: 10.1128/AAC.46.1.132-134.2002.
10
Spirochaetal lipoproteins and pathogenesis.螺旋体脂蛋白与发病机制。
Microbiology (Reading). 2000 Jul;146 ( Pt 7)(Pt 7):1491-1504. doi: 10.1099/00221287-146-7-1491.

本文引用的文献

1
Lyme disease-a tick-borne spirochetosis?莱姆病——一种蜱传播的螺旋体病?
Science. 1982 Jun 18;216(4552):1317-9. doi: 10.1126/science.7043737.
2
Spirochetes in Ixodes dammini and mammals from Connecticut.来自康涅狄格州的达氏硬蜱和哺乳动物体内的螺旋体。
Am J Trop Med Hyg. 1983 Jul;32(4):818-24. doi: 10.4269/ajtmh.1983.32.818.
3
Natural Distribution of the Ixodes dammini spirochete.达米尼硬蜱螺旋体的自然分布。
Science. 1983 Apr 15;220(4594):321-2. doi: 10.1126/science.6836274.
4
Spirochetes isolated from the blood of two patients with Lyme disease.从两名莱姆病患者血液中分离出的螺旋体。
N Engl J Med. 1983 Mar 31;308(13):740-2. doi: 10.1056/NEJM198303313081302.
5
The spirochetal etiology of Lyme disease.莱姆病的螺旋体病因
N Engl J Med. 1983 Mar 31;308(13):733-40. doi: 10.1056/NEJM198303313081301.
6
Infection of Syrian hamsters with Lyme disease spirochetes.用莱姆病螺旋体感染叙利亚仓鼠。
J Clin Microbiol. 1984 Dec;20(6):1099-101. doi: 10.1128/jcm.20.6.1099-1101.1984.
7
The spirochetal etiology of lymphocytic meningoradiculitis of Bannwarth (Bannwarth's syndrome).班沃特淋巴细胞性脑膜神经根炎(班沃特综合征)的螺旋体病因。
J Neurol. 1984;231(3):141-4. doi: 10.1007/BF00313682.
8
Treatment of the early manifestations of Lyme disease.莱姆病早期表现的治疗。
Ann Intern Med. 1983 Jul;99(1):22-6. doi: 10.7326/0003-4819-99-1-22.
9
[Clinical aspects and etiology of acrodermatitis chronica atrophicans].[慢性萎缩性肢端皮炎的临床特征与病因]
Hautarzt. 1984 Nov;35(11):571-7.
10
Isolation and cultivation of Lyme disease spirochetes.莱姆病螺旋体的分离与培养。
Yale J Biol Med. 1984 Jul-Aug;57(4):521-5.

莱姆病螺旋体伯氏疏螺旋体对四种抗菌药物的体外和体内敏感性

In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents.

作者信息

Johnson R C, Kodner C, Russell M

出版信息

Antimicrob Agents Chemother. 1987 Feb;31(2):164-7. doi: 10.1128/AAC.31.2.164.

DOI:10.1128/AAC.31.2.164
PMID:3566246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC174684/
Abstract

The antimicrobial susceptibility of Borrelia burgdorferi isolated from human spinal fluid was determined in vitro and in vivo. A broth dilution technique was used to determine the MBCs of four antimicrobial agents. The Lyme disease spirochete was most susceptible to ceftriaxone (MBC, 0.04 microgram/ml) and erythromycin (MBC, 0.05 microgram/ml), then tetracycline (MBC, 0.8 microgram/ml), and finally penicillin G (MBC, 6.4 micrograms/ml). Syrian hamsters were used to determine the 50% curative doses (CD50s) of the four antimicrobial agents. Ceftriaxone and tetracycline had the highest activities, with CD50s of 24.0 and 28.7 mg/kg [corrected], respectively. Both erythromycin and penicillin G possessed low activities. The CD50 of erythromycin was 235.3 mg/kg [corrected], and the CD50 of penicillin G was greater than 197.5 mg/kg [corrected].

摘要

对从人体脑脊液中分离出的伯氏疏螺旋体进行了体外和体内抗菌药敏试验。采用肉汤稀释技术测定了四种抗菌药物的最低杀菌浓度(MBC)。莱姆病螺旋体对头孢曲松(MBC,0.04微克/毫升)和红霉素(MBC,0.05微克/毫升)最敏感,其次是四环素(MBC,0.8微克/毫升),最后是青霉素G(MBC,6.4微克/毫升)。使用叙利亚仓鼠测定了这四种抗菌药物的50%治愈剂量(CD50)。头孢曲松和四环素活性最高,CD50分别为24.0和28.7毫克/千克[校正后]。红霉素和青霉素G活性较低。红霉素的CD50为235.3毫克/千克[校正后],青霉素G的CD50大于197.5毫克/千克[校正后]。